Martin A. Weiler - Concepedia

Author

Martin A. Weiler

Also Known As

M A Weiler, M Weiler, M. Weiler, M.A. Weiler, MARTIN A. WEILER, Martin A Weiler, Martin A. Weiler, Martin Weiler, Weiler, Martin

Publications

Citations

H-Index

Concepts

All Affiliations

University of Maryland, Baltimore The University of Texas Southwestern Medical Center University of Alabama at Birmingham Southwestern Medical Center

About

Martin A. Weiler is an author at University of Maryland, Baltimore specializing in medicine, social sciences, and psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	1.7K
2	Social Sciences	14	15	1.3K
3	Anesthesia	3	3	443
4	Cognitive Science	2	2	168
5	Health Sciences	1	1	280

Martin A. Weiler

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Gamma and Delta Neural Oscillations and Association with Clinical Symptoms under Subanesthetic Ketamine L. Elliot Hong, Ann Summerfelt, Robert W. Buchanan, Neuropsychopharmacology Subanesthetic KetamineDelta Neural OscillationsClinical SymptomsHealth SciencesNeurophysiology	2009	280
Effects of Cognitive Treatment in Psychiatric Rehabilitation William D. Spaulding, Dorie Reed, M. Sullivan, Schizophrenia Bulletin NeuropsychologyPsychiatric EvaluationMental HealthCognitive RehabilitationPsychology	1999	265
Functional effects of antipsychotic drugs: comparing clozapine with haloperidol Adrienne C. Lahti, Henry H. Holcomb, Martin A. Weiler, Biological Psychiatry PsychiatryPsychotic DisorderMedicinePsychotropic MedicationPsychopharmacology	2003	133
Correlations Between rCBF and Symptoms in Two Independent Cohorts of Drug-Free Patients with Schizophrenia Adrienne C. Lahti, Martin A. Weiler, Henry H. Holcomb, Neuropsychopharmacology Correlations Between RcbfDrug-free PatientsPsychiatryPsychotic DisorderPsychopharmacology	2005	132
Modulation of Limbic Circuitry Predicts Treatment Response to Antipsychotic Medication: A Functional Imaging Study in Schizophrenia Adrienne C. Lahti, Martin A. Weiler, Henry H. Holcomb, Neuropsychopharmacology Functional Imaging StudyPsychiatryPsychotic DisorderMedicinePsychotropic Medication	2009	106
Antipsychotic Properties of the Partial Dopamine Agonist (−)-3-(3-Hydroxyphenyl)-N-n-Propylpiperidine (Preclamol) in Schizophrenia Adrienne C. Lahti, Martin A. Weiler, Patricia K. Corey, Biological Psychiatry PsychiatryAntipsychotic PropertiesMedicinePsychotropic MedicationPsychopharmacology	1998	105
Abnormal Patterns of Regional Cerebral Blood Flow in Schizophrenia With Primary Negative Symptoms During an Effortful Auditory Recognition Task Adrienne C. Lahti, Henry H. Holcomb, Deborah R. Medoff, American Journal of Psychiatry	2001	105
Insight and symptom change in schizophrenia and other disorders Martin A. Weiler, Mark H. Fleisher, Delores McArthur-Campbell Schizophrenia Research PsychiatryPsychotic DisorderPsychologySchizophreniaSocial Sciences	2000	99
The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers Arti Parwani, Martin A. Weiler, Teresa A. Blaxton, Psychopharmacology NeuropsychologyCognitive ScienceMnemonicSubanesthetic DoseMedicine	2005	86
Clozapine but not Haloperidol Re-establishes Normal Task-Activated rCBF Patterns in Schizophrenia within the Anterior Cingulate Cortex Adrienne C. Lahti, Henry H. Holcomb, Martin A. Weiler, Neuropsychopharmacology NeuropsychologyBrain FunctionPsychotropic MedicationAffective NeurosciencePsychopharmacology	2003	82

Page 1